Nisha Pandey

Health and Me

From 365 Shots To 52: How Could Lilly’s Newly-Approved Weekly Insulin Injection Change Diabetes Care

For years, people with type 2 diabetes who needed <span>insulin</span> had to administer an injection daily. Eli <span>Lilly</span>’s newly approved insulin is set to bring a dramatic reduction in that burden from roughly 365 injections a year to just 52.

The <span>US Food and Drug Administration</span> (<span>FDA</span>) has approved <span>Onswik</span> (insulin efsitora alfa-gobe), a once-weekly basal insulin for adults with type 2 diabetes. It is designed to provide a steady level of insulin over seven days and is used alongside diet and exercise to control blood sugar. Find out how different weekly insulin is from the daily shots that patients are used to?

<h2>Lilly's Once-Weekly Insulin Gets FDA Approval</h2>

<a href="https://www.healthandme.com/parenting/gut-microbiome-linked-to-3x-higher-type-1-diabetes-risk-in-children-article-156198602" data-type="tilCustomLink">Insulin</a> is a hormone that helps glucose move from the bloodstream into cells, where it can be used for energy. It also helps reduce the amount of glucose produced by the liver. People with type 2 diabetes may eventually need insulin when their bodies do not produce enough of it or cannot use it effectively.

Basal insulin is long-acting insulin designed to work in the background throughout the day and night, helping keep blood sugar levels under control between meals and overnight.

Until now, commonly used basal insulins like insulin glargine and insulin degludec have generally required daily injections.

<a href="https://www.healthandme.com/health-wellness/elderly-diabetic-with-rock-hard-arteries-undergoes-advanced-calcium-breaking-heart-procedure-avoids-high-risk-surgery-article-156213539" data-type="tilCustomLink">Onswik</a> is a long-acting insulin analogue designed to remain active for an entire week. Instead of injecting a smaller amount every day, patients receive one subcutaneous injection on the same day each week. That could reduce the number of basal insulin injections by more than 300 a year compared with daily treatment. 

For someone who finds daily injections difficult to maintain, that development could be gamechanging.

Also read: <a href="https://www.healthandme.com/health-news/cagrisema-beats-lillys-mounjaro-zepbound-in-new-trial-all-about-novos-next-gen-obesity-drug-article-156201817" data-type="tilCustomLink">CagriSema Beats Lilly’s Mounjaro &amp; Zepbound In New Trial: All About Novo’s Next-Gen Obesity Drug</a>

<h2>Comparison Between Weekly Insulin &amp; Daily Insulin</h2>

Lilly's late-stage <span>QWINT</span> programme included more than 3,400 adults with type 2 diabetes across four Phase 3 studies. Onswik met its primary goal in each study, reducing HbA1c, a measure of average blood sugar over time, by an amount that was not inferior to daily basal insulin. 

The studies included people who had never previously used insulin as well as people already receiving insulin treatment.

So the significance of the approval is not that <a href="https://www.healthandme.com/health-wellness/brain-health-after-40-why-diabetes-menopause-and-early-detection-matter-world-alzheimers-day-article-156197603" data-type="tilCustomLink">weekly insulin</a> necessarily works better than daily insulin. Rather, it offers comparable blood-sugar control with far fewer injections.

Taking insulin every day can become another task in an already demanding diabetes care routine. Missed or delayed doses can make blood sugar management more difficult. A weekly option could simplify treatment for some patients and potentially make it easier to stay consistent. But convenience does not mean the treatment becomes risk-free.

Also read: <a href="https://www.healthandme.com/health-news/hundreds-of-american-glp-1-users-sue-novo-nordisk-eli-lilly-over-vision-loss-what-is-naion-article-156200838" data-type="tilCustomLink">Hundreds Of American GLP-1 Users Sue Novo Nordisk, Eli Lilly Over Vision Loss: What Is NAION?</a>

<h2>What Are The Risks &amp; Who Can Take It?</h2>

Statins for High Cholesterol Explained: Who Needs Them, Side Effects & Long-Term Use

The most important risk remains hypoglycaemia, or dangerously low <a href="https://www.healthandme.com/health-news/stopping-ozempic-wegovy-mounjaro-linked-to-22-higher-heart-attack-stroke-risk-study-article-156211503" data-type="tilCustomLink">blood sugar</a>, which is a known risk with insulin.

Severe hypoglycaemia can cause confusion, seizures, loss of consciousness and, in serious cases, death. 

Other reported adverse effects of Onswik include allergic reactions, injection-site reactions, changes in fat tissue at injection sites, itching, rash, swelling and weight gain.

The FDA also warns about medication errors and accidental overdose, low potassium levels and fluid retention or heart failure when the medicine is used with certain other drugs. 

The FDA approval is specifically for adults with type 2 diabetes. Onswik is not recommended for people with type 1 diabetes due to the risk of severe hypoglycaemia. It is also not a replacement for other aspects of diabetes management. 

Health Conditions A-Z

health

from-365-shots-to-52-how-could-lillys-newly-approved-weekly-insulin-injection-change-diabetes-care

once weekly insulin

insulin

onswik

lilly

eli lillys

us food and drug administration

qwint

485-inactive-chemicals-in-us-pesticide-products-linked-to-breast-cancer

485 'Inactive' Chemicals In US Pesticide Products Linked To Breast Cancer

fda-approves-new-drug-for-rare-disorder-that-turns-muscles-into-bone-what-is-fop

FDA Approves New Drug For Rare Disorder That Turns Muscles Into Bone: What Is Fibrodysplasia Ossificans Progressiva?

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

For years, people with type 2 diabetes who needed insulin had to administer an injection daily. Eli Lilly’s newly approved insulin is set to bring a dramatic reduction in that burden from roughly 365 injections a year to just 52.The US Food and Drug Administration (FDA) has approved Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin for adults with type 2 diabetes. It is designed to provide a steady level of insulin over seven days and is used alongside diet and exercise to control blood sugar. Find out how different weekly insulin is from the daily shots that patients are used to?Lilly's Once-Weekly Insulin Gets FDA ApprovalInsulin is a hormone that helps glucose move from the bloodstream into cells, where it can be used for energy. It also helps reduce the amount of glucose produced by the liver. People with type 2 diabetes may eventually need insulin when their bodies do not produce enough of it or cannot use it effectively.Basal insulin is long-acting insulin designed to work in the background throughout the day and night, helping keep blood sugar levels under control between meals and overnight.Until now, commonly used basal insulins like insulin glargine and insulin degludec have generally required daily injections.Onswik is a long-acting insulin analogue designed to remain active for an entire week. Instead of injecting a smaller amount every day, patients receive one subcutaneous injection on the same day each week. That could reduce the number of basal insulin injections by more than 300 a year compared with daily treatment. For someone who finds daily injections difficult to maintain, that development could be gamechanging.Also read: CagriSema Beats Lilly’s Mounjaro & Zepbound In New Trial: All About Novo’s Next-Gen Obesity DrugComparison Between Weekly Insulin & Daily InsulinLilly's late-stage QWINT programme included more than 3,400 adults with type 2 diabetes across four Phase 3 studies. Onswik met its primary goal in each study, reducing HbA1c, a measure of average blood sugar over time, by an amount that was not inferior to daily basal insulin. The studies included people who had never previously used insulin as well as people already receiving insulin treatment.So the significance of the approval is not that weekly insulin necessarily works better than daily insulin. Rather, it offers comparable blood-sugar control with far fewer injections.Taking insulin every day can become another task in an already demanding diabetes care routine. Missed or delayed doses can make blood sugar management more difficult. A weekly option could simplify treatment for some patients and potentially make it easier to stay consistent. But convenience does not mean the treatment becomes risk-free.Also read: Hundreds Of American GLP-1 Users Sue Novo Nordisk, Eli Lilly Over Vision Loss: What Is NAION?What Are The Risks & Who Can Take It?               The most important risk remains hypoglycaemia, or dangerously low blood sugar, which is a known risk with insulin.Severe hypoglycaemia can cause confusion, seizures, loss of consciousness and, in serious cases, death. Other reported adverse effects of Onswik include allergic reactions, injection-site reactions, changes in fat tissue at injection sites, itching, rash, swelling and weight gain.The FDA also warns about medication errors and accidental overdose, low potassium levels and fluid retention or heart failure when the medicine is used with certain other drugs. The FDA approval is specifically for adults with type 2 diabetes. Onswik is not recommended for people with type 1 diabetes due to the risk of severe hypoglycaemia. It is also not a replacement for other aspects of diabetes management. 

from 365 shots to 52: how could lilly’s newly-approved weekly insulin injection change diabetes care

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

From 365 Shots To 52: How Could Lilly’s Newly-Approved Weekly Insulin Injection Change Diabetes Care

485 'Inactive' Chemicals In US Pesticide Products Linked To Breast Cancer

FDA Approves New Drug For Rare Disorder That Turns Muscles Into Bone: What Is Fibrodysplasia Ossificans Progressiva?

Mpox Case Detected In Congo’s Ituri Amid Ebola Outbreak: Why Are Health Officials Concerned?

Health Conditions A-Z

From 365 Shots To 52: How Could Lilly’s Newly-Approved Weekly Insulin Injection Change Diabetes Care

485 'Inactive' Chemicals In US Pesticide Products Linked To Breast Cancer

FDA Approves New Drug For Rare Disorder That Turns Muscles Into Bone: What Is Fibrodysplasia Ossificans Progressiva?